Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Michael E, Minshall"'
Autor:
Timothy J. Inocencio, Kimberly L. Sterling, Sibel Sayiner, Michael E. Minshall, Leanne Kaye, Umur Hatipoğlu
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Chronic obstructive pulmonary disease (COPD) is a progressive debilitating condition with frequent exacerbations that have a high burden for patients and society. Digital tools may help to reduce the economic burden for patients a
Externí odkaz:
https://doaj.org/article/e73dd19452a240ada4ea7cd9ab0a07a8
Autor:
Michael E Minshall, Robert Kemp, Emilie Hofstetter, Gerhard Boerner, Jennifer McGrain, Shahid Jamil Siddiqui
Publikováno v:
Transplantation and Cellular Therapy. 29:S358-S359
Publikováno v:
Journal of Clinical Movement Disorders, Vol 7, Iss 1, Pp 1-8 (2020)
Journal of Clinical Movement Disorders
Journal of Clinical Movement Disorders
Background The Personal KinetiGraph® (PKG®) Movement Recording System provides continuous, objective, ambulatory movement data during routine daily activities and provides information on medication compliance, motor fluctuations, immobility, and tr
Publikováno v:
Diabetes. 69
A BIA was performed comparing clinical cost offsets for rt-CGM compared with SMBG for U.S. Medicaid enrollees with type 1 diabetes (T1D) over one year. Clinical effects for HbA1c reduction using rt-CGM (-1.0%) and SMBG (-0.4%) were taken from the DIA
Autor:
George Grunberger, Martin Prazny, Jan Šoupal, Michael E. Minshall, P. Lynch, Christopher G. Parkin, John J. Isitt
Publikováno v:
Diabetes. 69
This clinical cost offset analysis compared rtCGM vs. SMBG in people with type 1 diabetes (T1D) applying results from a 3-year, nonrandomized, prospective, real-world clinical trial (COMISAIR). Clinical effects for HbA1c reduction using rtCGM vs. SMB
Autor:
Sandra L. Tunis, Michael E. Minshall
Publikováno v:
Current Medical Research and Opinion. 26:151-162
Stakeholders in the US and elsewhere are interested in country-specific and cohort-specific information with which to assess the long-term value of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes mellitus (T2DM) on oral anti
Publikováno v:
Value in Health. 12:674-686
Objective To estimate the long-term cost-effectiveness of using continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) of insulin in adult and child/young adult type 1 diabetes mellitus (T1DM) patients from a th
Autor:
Sandra L. Tunis, Michael E. Minshall
Publikováno v:
Diabetes Technology & Therapeutics. 10:227-231
One source of variation in cost-effectiveness analyses stems from the characteristics of the study upon which each is based. This report provides cost-effectiveness analyses using data from a recently published randomized clinical trial (RCT) compari
Autor:
Lyn Sharon-Nash, William J. Valentine, Katerina Zakrzewska, Neale Cohen, Andrew J. Palmer, Michael E. Minshall
Publikováno v:
PharmacoEconomics. 25:881-897
Background: Recent meta-analyses in the published medical literature have found improved glycaemic control with continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) of insulin for patients with diabetes mellit
Autor:
Robert, Pivec, Michael E, Minshall, Jaydev B, Mistry, Morad, Chughtai, Randa K, Elmallah, Michael A, Mont
Publikováno v:
Surgical technology international. 27
Chronic low back pain (CLBP) may be treated without opioids through the use of transcutaneous electrical nerve stimulation (TENS). However, no study has evaluated its clinical effect and economic impact as measured by opioid utilization and costs. Th